631 related articles for article (PubMed ID: 29604224)
1. Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects.
Seong E; Insolera R; Dulovic M; Kamsteeg EJ; Trinh J; Brüggemann N; Sandford E; Li S; Ozel AB; Li JZ; Jewett T; Kievit AJA; Münchau A; Shakkottai V; Klein C; Collins CA; Lohmann K; van de Warrenburg BP; Burmeister M
Ann Neurol; 2018 Jun; 83(6):1075-1088. PubMed ID: 29604224
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing confirms implication of VPS13D as a potential cause of progressive spastic ataxia.
Durand CM; Angelini C; Michaud V; Delleci C; Coupry I; Goizet C; Trimouille A
BMC Neurol; 2022 Feb; 22(1):53. PubMed ID: 35151251
[TBL] [Abstract][Full Text] [Related]
3. Hypomorphic mutations in POLR3A are a frequent cause of sporadic and recessive spastic ataxia.
Minnerop M; Kurzwelly D; Wagner H; Soehn AS; Reichbauer J; Tao F; Rattay TW; Peitz M; Rehbach K; Giorgetti A; Pyle A; Thiele H; Altmüller J; Timmann D; Karaca I; Lennarz M; Baets J; Hengel H; Synofzik M; Atasu B; Feely S; Kennerson M; Stendel C; Lindig T; Gonzalez MA; Stirnberg R; Sturm M; Roeske S; Jung J; Bauer P; Lohmann E; Herms S; Heilmann-Heimbach S; Nicholson G; Mahanjah M; Sharkia R; Carloni P; Brüstle O; Klopstock T; Mathews KD; Shy ME; de Jonghe P; Chinnery PF; Horvath R; Kohlhase J; Schmitt I; Wolf M; Greschus S; Amunts K; Maier W; Schöls L; Nürnberg P; Zuchner S; Klockgether T; Ramirez A; Schüle R
Brain; 2017 Jun; 140(6):1561-1578. PubMed ID: 28459997
[TBL] [Abstract][Full Text] [Related]
4. A novel GBA2 gene missense mutation in spastic ataxia.
Votsi C; Zamba-Papanicolaou E; Middleton LT; Pantzaris M; Christodoulou K
Ann Hum Genet; 2014 Jan; 78(1):13-22. PubMed ID: 24252062
[TBL] [Abstract][Full Text] [Related]
5. Recessive mutations in VPS13D cause childhood onset movement disorders.
Gauthier J; Meijer IA; Lessel D; Mencacci NE; Krainc D; Hempel M; Tsiakas K; Prokisch H; Rossignol E; Helm MH; Rodan LH; Karamchandani J; Carecchio M; Lubbe SJ; Telegrafi A; Henderson LB; Lorenzo K; Wallace SE; Glass IA; Hamdan FF; Michaud JL; Rouleau GA; Campeau PM
Ann Neurol; 2018 Jun; 83(6):1089-1095. PubMed ID: 29518281
[TBL] [Abstract][Full Text] [Related]
6. Recessive null-allele variants in MAG associated with spastic ataxia, nystagmus, neuropathy, and dystonia.
Zech M; Brunet T; Škorvánek M; Blaschek A; Vill K; Hanker B; Hüning I; Haň V; Došekova P; Gdovinová Z; Alhaddad B; Berutti R; Strom TM; Růžička E; Kamsteeg EJ; van der Smagt JJ; Wagner M; Jech R; Winkelmann J
Parkinsonism Relat Disord; 2020 Aug; 77():70-75. PubMed ID: 32629324
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel homozygous SPG7 mutation in a Japanese patient with spastic ataxia: making an efficient diagnosis using exome sequencing for autosomal recessive cerebellar ataxia and spastic paraplegia.
Doi H; Ohba C; Tsurusaki Y; Miyatake S; Miyake N; Saitsu H; Kawamoto Y; Yoshida T; Koyano S; Suzuki Y; Kuroiwa Y; Tanaka F; Matsumoto N
Intern Med; 2013; 52(14):1629-33. PubMed ID: 23857099
[TBL] [Abstract][Full Text] [Related]
8. Increasing involvement of CAPN1 variants in spastic ataxias and phenotype-genotype correlations.
Méreaux JL; Firanescu C; Coarelli G; Kvarnung M; Rodrigues R; Pegoraro E; Tazir M; Taithe F; Valter R; Huin V; Lidström K; Banneau G; Morais S; Parodi L; Coutelier M; Papin M; Svenningsson P; Azulay JP; Alonso I; Nilsson D; Brice A; Le Guern E; Press R; Vazza G; Loureiro JL; Goizet C; Durr A; Paucar M; Stevanin G
Neurogenetics; 2021 Mar; 22(1):71-79. PubMed ID: 33486633
[TBL] [Abstract][Full Text] [Related]
9. Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination.
Chelban V; Patel N; Vandrovcova J; Zanetti MN; Lynch DS; Ryten M; Botía JA; Bello O; Tribollet E; Efthymiou S; Davagnanam I; ; Bashiri FA; Wood NW; Rothman JE; Alkuraya FS; Houlden H
Am J Hum Genet; 2017 Jun; 100(6):969-977. PubMed ID: 28575651
[TBL] [Abstract][Full Text] [Related]
10. SPG7 mutations explain a significant proportion of French Canadian spastic ataxia cases.
Choquet K; Tétreault M; Yang S; La Piana R; Dicaire MJ; Vanstone MR; Mathieu J; Bouchard JP; Rioux MF; Rouleau GA; ; Boycott KM; Majewski J; Brais B
Eur J Hum Genet; 2016 Jul; 24(7):1016-21. PubMed ID: 26626314
[TBL] [Abstract][Full Text] [Related]
11. Novel CAPN1 mutations extend the phenotypic heterogeneity in combined spastic paraplegia and ataxia.
Lai LL; Chen YJ; Li YL; Lin XH; Wang MW; Dong EL; Wang N; Chen WJ; Lin X
Ann Clin Transl Neurol; 2020 Oct; 7(10):1862-1869. PubMed ID: 32860341
[TBL] [Abstract][Full Text] [Related]
12. Neurological Phenotypes Associated with AAAS-Related Disorders: Spastic Ataxia and Complex Spastic Paraplegia.
Lorea CF; Tenório RB; Koenig M; Huebner A; Koehler K; Devos D; Guissart C; Saute JAM
Cerebellum; 2020 Jun; 19(3):465-468. PubMed ID: 32146693
[No Abstract] [Full Text] [Related]
13. CAPN1 mutations: Expanding the CAPN1-related phenotype: From hereditary spastic paraparesis to spastic ataxia.
Shetty A; Gan-Or Z; Ashtiani S; Ruskey JA; van de Warrenburg B; Wassenberg T; Kamsteeg EJ; Rouleau GA; Suchowersky O
Eur J Med Genet; 2019 Dec; 62(12):103605. PubMed ID: 30572172
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.
Park J; Tucci A; Cipriani V; Demidov G; Rocca C; Senderek J; Butryn M; Velic A; Lam T; Galanaki E; Cali E; Vestito L; Maroofian R; Deininger N; Rautenberg M; Admard J; Hahn GA; Bartels C; van Os NJH; Horvath R; Chinnery PF; Tiet MY; Hewamadduma C; Hadjivassiliou M; Tofaris GK; ; Wood NW; Hayer SN; Bender F; Menden B; Cordts I; Klein K; Nguyen HP; Krauss JK; Blahak C; Strom TM; Sturm M; van de Warrenburg B; Lerche H; Maček B; Synofzik M; Ossowski S; Timmann D; Wolf ME; Smedley D; Riess O; Schöls L; Houlden H; Haack TB; Hengel H
Genet Med; 2022 Oct; 24(10):2079-2090. PubMed ID: 35986737
[TBL] [Abstract][Full Text] [Related]
15. A homozygous missense variant in the homeobox domain of the NKX6-2 results in progressive spastic ataxia type 8 associated with lower limb weakness and neurological manifestations.
Almatrafi A; Umair M; Eldardear A; Al-Luqmani M; Hashmi JA; Albalawi AM; Alfadhel M; Ramzan K; Basit S
J Gene Med; 2020 Aug; 22(8):e3196. PubMed ID: 32246862
[TBL] [Abstract][Full Text] [Related]
16. POLR3A-related spastic ataxia: new mutations and a look into the phenotype.
Infante J; Serrano-Cárdenas KM; Corral-Juan M; Farré X; Sánchez I; de Lucas EM; García A; Martín-Gurpegui JL; Berciano J; Matilla-Dueñas A
J Neurol; 2020 Feb; 267(2):324-330. PubMed ID: 31637490
[TBL] [Abstract][Full Text] [Related]
17. VPS13D-based disease: Expansion of the clinical phenotype in two brothers and mutation diversity in the Turkish population.
Öztop-Çakmak Ö; Şimşir G; Tekgül Ş; Aygün MS; Gökler O; Kahyaoğlu B; Kaya ZE; Palvadeau R; Başak AN; Ertan S
Rev Neurol (Paris); 2022 Nov; 178(9):907-913. PubMed ID: 36156252
[TBL] [Abstract][Full Text] [Related]
18. A Diagnostic Approach to Spastic ataxia Syndromes.
Pedroso JL; Vale TC; França Junior MC; Kauffman MA; Teive H; Barsottini OGP; Munhoz RP
Cerebellum; 2022 Dec; 21(6):1073-1084. PubMed ID: 34782953
[TBL] [Abstract][Full Text] [Related]
19. Intrafamilial variable spastic paraplegia/ataxia/ALS phenotype linked to a novel KIF5A mutation.
Faruq M; Kumar D; Wadhwa S; Shamim U; Mathur A; Parveen S; Garg A; Srivastava AK
Clin Genet; 2019 Sep; 96(3):271-273. PubMed ID: 31286494
[No Abstract] [Full Text] [Related]
20. Late-onset spastic ataxia phenotype in a patient with a homozygous DDHD2 mutation.
Doi H; Ushiyama M; Baba T; Tani K; Shiina M; Ogata K; Miyatake S; Fukuda-Yuzawa Y; Tsuji S; Nakashima M; Tsurusaki Y; Miyake N; Saitsu H; Ikeda S; Tanaka F; Matsumoto N; Yoshida K
Sci Rep; 2014 Nov; 4():7132. PubMed ID: 25417924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
